Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,485 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,566 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07499128 | Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event | enrolling by invitation | N/A | 136 | National Cancer Institute (NCI)NIH | 1 | Jun 25, 2026 | clinicaltrials |
| NCT02427269 | University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository(BEECAB) | enrolling by invitation | — | 1,000 | University of North Carolina, Chapel HillOTHER | 1 |
| Jun 24, 2026 |
| clinicaltrials |
| NCT07275463 | [99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression | enrolling by invitation | Phase 2 | 40 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07292571 | Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107 | enrolling by invitation | Phase 2 | 50 | Tomsk National Research Medical Center of the Russian Academy of SciencesOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT03393962 | Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors | enrolling by invitation | Phase 1 / Phase 2 | 20 | Shenzhen Geno-Immune Medical InstituteOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT05435859 | Functional Organization of the Superior Temporal Gyrus for Speech Perception | enrolling by invitation | N/A | 60 | University of California, San FranciscoOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT06583564 | The Prognosis Effect of Indocyanine Green (ICG) Fluorescence Guided Surgery on Disease-free Survival (DFS) of Stage III Colorectal Cancer | enrolling by invitation | N/A | 192 | Shanghai Tong Ren HospitalOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT07217353 | The Use of a Novel Vaginal Speculum for Endometrial Biopsies | enrolling by invitation | N/A | 100 | Rocky Vista University, LLCOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT02600949 | Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer | enrolling by invitation | Phase 1 | 300 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT07198945 | Six Versus Twelve Month Index Follow-up After Large Colon Polyp Resection(STARLING) | enrolling by invitation | N/A | 546 | Indiana UniversityOTHER | 3 | Jun 17, 2026 | clinicaltrials |
| NCT07307833 | Impact of Immunotherapy on Vestibular Function, The Mayo Clinic Arizona Experience | enrolling by invitation | — | 50 | Mayo ClinicOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07651163 | Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy | enrolling by invitation | Phase 2 / Phase 3 | 450 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07651176 | Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy | enrolling by invitation | Phase 2 / Phase 3 | 267 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07651345 | Trial to Evaluate the Impact of Various Pragmatic Interventions to Increase Mammography Uptake Among Defaulted Repeat Screeners in Singapore(REMIND1) | enrolling by invitation | N/A | 12,750 | National University Hospital, SingaporeOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT07644845 | MammoVerse: Clinicians Focus Group | enrolling by invitation | — | 12 | University of Central FloridaOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT06985576 | Long-term Study to Evaluate Safety and Persistence of GF-CART01 | enrolling by invitation | — | 18 | GenomeFrontier Therapeutics TW Co., Ltd.INDUSTRY | 1 | Jun 11, 2026 | clinicaltrials |
| NCT07218003 | A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 | enrolling by invitation | Phase 1 | 149 | Rondo TherapeuticsINDUSTRY | 1 | Jun 11, 2026 | clinicaltrials |
| NCT07186530 | Offering HPV Self-Collection in Novel Healthcare Settings to Improve Uptake of Cervical Cancer Screening | enrolling by invitation | N/A | 500 | Mayo ClinicOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT07634575 | Triggered Imaging in Glioblastoma Based on Clinical Outcome Evaluation Compared to Routine: a Feasibility Study(TIGER F) | enrolling by invitation | N/A | 20 | King's College Hospital NHS TrustOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT07633353 | Real-World Outcomes of First-Line Treatment of Metastatic or Locally Advanced Upper Tract Urothelial Carcinoma With Enfortumab Vedotin Plus Pembrolizumab : A French Multicenter Retrospective Observational Study(UTUC PROVE) | enrolling by invitation | — | 50 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Jun 8, 2026 | clinicaltrials |
| NCT06967467 | Allergy Delabeling in Antibiotic Stewardship - Evaluations(RENEW-EVAL) | enrolling by invitation | — | 80 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT06744595 | Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer | enrolling by invitation | N/A | 50 | Mayo ClinicOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT07621757 | The Implementation of Genetic Risk for Colorectal Cancer Screening(PRO-GENE-COLON) | enrolling by invitation | — | 100 | Endeavor HealthOTHER | 1 | Jun 2, 2026 | clinicaltrials |
| NCT07618624 | BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression(BRIDGE) | enrolling by invitation | Phase 2 | 42 | Sun Yat-sen UniversityOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT05116137 | The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors(RESIST) | enrolling by invitation | N/A | 24 | Nova Scotia Health AuthorityOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT06924788 | Video-Conferenced Stress Management and Relaxation Training (VSMART) For Alabama Breast Cancer Survivors(VSMART) | enrolling by invitation | N/A | 25 | University of Alabama at BirminghamOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT07606638 | Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients | enrolling by invitation | N/A | 98 | Mayo Hospital LahoreOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT06437288 | Hematoporphyrin Photodynamic Therapy for Esophageal Cancer | enrolling by invitation | Phase 4 | 198 | Sun Yat-sen UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06935097 | Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer | enrolling by invitation | N/A | 25 | M.D. Anderson Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07240857 | A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer | enrolling by invitation | Early Phase 1 | 18 | Zhejiang UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07594327 | Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer | enrolling by invitation | — | 21 | Tampere University HospitalOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07603167 | p-PHOTOLARYNX- ANTHEM: Photon-Counting CT in Laryngeal Cancer Staging(H&NRAD-2025-01) | enrolling by invitation | — | 60 | Humanitas UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06885424 | A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products(DESCENT-1) | enrolling by invitation | — | 400 | A2 Biotherapeutics Inc.INDUSTRY | 1 | May 20, 2026 | clinicaltrials |
| NCT07595666 | Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region. | enrolling by invitation | N/A | 1,600 | prof. dr. Koen Van LaereOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT04399876 | Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer | enrolling by invitation | Phase 1 | 35 | Brigham and Women's HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT06204614 | Drug Screening Using IMD in Bladder Cancer | enrolling by invitation | Early Phase 1 | 18 | Brigham and Women's HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT06324110 | Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial | enrolling by invitation | N/A | 6,772 | Fred Hutchinson Cancer CenterOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT06782399 | Drug Screening of Cutaneous Lesions of Squamous Cell Carcinoma(SCC) | enrolling by invitation | Early Phase 1 | 25 | Oliver JonasOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07587411 | Stepped-Care Support for Children With Leukaemia(STEP-Leukemia) | enrolling by invitation | N/A | 96 | Zhengzhou UniversityOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07557901 | A Study Comparing Infectious Complications After Transperineal Prostate Biopsy With or Without Antibiotic Prophylaxis | enrolling by invitation | N/A | 300 | F.D. Roosevelt Teaching Hospital with Policlinic Banska BystricaOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT07298980 | ExBRAC- Expressive Writing in Breast Cancer(ExBRAC) | enrolling by invitation | N/A | 272 | Region SkaneOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT07583160 | YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer(YS247) | enrolling by invitation | Phase 1 | 18 | Changhai HospitalOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT05486520 | Low-field MRI for Breast Cancer Screening | enrolling by invitation | N/A | 40 | Massachusetts General HospitalOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT07253298 | The Effects of Kegel Exercise Combined With Biofeedback Therapy on Bowel Function Recovery, Emotional Distress, and Quality of Life in Patients Following Low Anterior Resection for Rectal Cancer(BFT in LARS) | enrolling by invitation | N/A | 66 | National Taiwan University HospitalOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT07575230 | Suzetrigine vs Norco-postoperative Mohs Pain | enrolling by invitation | Phase 4 | 75 | Baylor Research InstituteOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT06085560 | Choose It and Use It: Choice, Implementation Intentions and At-Home Colorectal Cancer Screening | enrolling by invitation | N/A | 600 | Michigan State UniversityOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07576049 | COLORECTAL CANCER: SINGLE CENTER EXPERIENCE(CRC URomLS) | enrolling by invitation | — | 37 | University of Roma La SapienzaOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT03295279 | WTC Chest CT Imaging Archive | enrolling by invitation | — | 2,122 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT03503240 | Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery | enrolling by invitation | — | 3,000 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 6, 2026 | clinicaltrials |
Data updated 23 days agoSource updated Jun 25, 2026source: clinicaltrials